UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019768
Receipt number R000022827
Scientific Title The efficacy of EUS-FNA with wet suction technique (WEST) for auto immune pancreatitis
Date of disclosure of the study information 2015/11/12
Last modified on 2022/05/19 09:28:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of EUS-FNA with wet suction technique (WEST) for auto immune pancreatitis

Acronym

The efficacy of EUS-FNA with WEST for AIP

Scientific Title

The efficacy of EUS-FNA with wet suction technique (WEST) for auto immune pancreatitis

Scientific Title:Acronym

The efficacy of EUS-FNA with WEST for AIP

Region

Japan


Condition

Condition

Autoimmune pancreatitis (AIP) type 1

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of EUS-FNA with wet suqtion technique (WEST) for AIP type 1

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The diagnosability of 4 items described for LPSP in Internal consensus diagnostic criteria

Key secondary outcomes

1.The number of IgG4 positive plasma cells in a high power field
2.Complications
3.The number of needle passes for sampling
4.The number needle passes
5.Whether can take sufficient quantitiy for immunostaining or not


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Needles of EUS-FNA were flushed with saline solution.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

AIP patients older than 20 years with elevated serum IgG4

Key exclusion criteria

1. AIP patients without elevated serum IgG4.
2. AIP patients who have already been performed steroid therapy.
3. EUS-FNA is impossible (cannot insert the scope, profound bleeding risk, etc)
4. Patients who cannot stop antithorombotic drugs for EUS-FNA.
5. Patients who don't agree with informed consent.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Hiromasa
Middle name
Last name Ohira

Organization

Fukushima Medical University, School of Medicine

Division name

Department of Gastroenterology

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima City, Fukushima Prefecture

TEL

024-547-1202

Email

h-ohira@fmu.ac.jp


Public contact

Name of contact person

1st name Mitsuru
Middle name
Last name Sugimoto

Organization

Fukushima Medical University, School of Medicine

Division name

Department of Gastroenterology

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima City, Fukushima Prefecture

TEL

024-547-1202

Homepage URL


Email

kita335@fmu.ac.jp


Sponsor or person

Institute

Department of Gastroenterology, Fukushima Medical University, School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Gastroenterology, Fukushima Medical University, School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University

Address

Hikarigaoka 1, Fukushima City, Japan

Tel

024-547-1825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 11 Month 12 Day

Date of IRB

2015 Year 10 Month 22 Day

Anticipated trial start date

2015 Year 11 Month 12 Day

Last follow-up date

2030 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 12 Day

Last modified on

2022 Year 05 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022827


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name